1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. RET

RET 

RET (REarranged during Transfection) is a transmembrane receptor tyrosine kinase that is activated by a complex consisting of a soluble glial cell line-derived neurotrophic factor (GDNF) family ligand (GFL) and a glycosyl phosphatidylinositol-anchored co-receptor, GDNF family receptors alpha (GFRalpha).

RET signalling is crucial for the development of the enteric nervous system. RET regulates the development of sympathetic, parasympathetic, motor, and sensory neurons, and is necessary for the postnatal maintenance of dopaminergic neurons. RET also plays a role as a driver oncogene in a variety of human cancers. Fusion of RET with several partner genes has been detected in papillary thyroid, lung, colorectal, pancreatic, and breast cancers, and tyrosine kinase inhibitors (TKIs) for RET (particularly RET-specific inhibitors) show promising effects against such cancers.

RET 相关产品 (7):

目录号 产品名 作用方式 纯度
  • HY-124401
    BT-13 Agonist ≥99.0%
    BT-13 是有效的、胶质细胞源性神经营养因子 (GDNF) 受体 RET 的选择性激动剂 (独立于 GDNF 配体发挥作用),促进体外感觉神经元神经突生长,减轻大鼠神经病变的发生。
  • HY-15002
    AST 487 Inhibitor 99.20%
    AST 487 是一种 RET 激酶抑制剂,IC50 为 880 nM,抑制 RET 自磷酸化,及下游效应器激活,也抑制 Flt-3IC50 为 520 nM。
  • HY-110193
    SPP-86 Inhibitor ≥99.0%
    SPP-86 是一种选择性的 RET 酪氨酸激酶的有效抑制剂,其 IC50 值为 8 nM。SPP-86 抑制 MCF7 细胞中 RET 诱导激活的 PI3K/Akt 和 MAPK 信号通路,也能抑制 RET 诱导的 ERα 磷酸化。
  • HY-15769
    WHI-P180 Inhibitor 99.76%
    WHI-P180 (Janex 3)是多种激酶抑制剂;抑制 RETKDREGFRIC50 值分别为5 nM,66 nM 和4 μM。
  • HY-U00437
    Pz-1 Inhibitor ≥99.0%
    Pz-1是有效地 RETVEGFR2 受体酪氨酸激酶抑制剂,Pz-1抑制这两个野生型激酶的 IC50 值小于 1 nM。
  • HY-101246
    RPI-1 Inhibitor
    RPI-1 是一种特异的口服 2-吲哚啉酮 Ret 酪氨酸激酶抑制剂。RPI-1 抑制人甲状腺髓样癌 TT 细胞增殖、Ret 酪氨酸磷酸化、Ret 蛋白表达及 PLCgamma、ERKs 和 AKT 的活化。具有抗肿瘤活性。
  • HY-15769A
    WHI-P180 hydrochloride Inhibitor
    WHI-P180 (Janex 3)是多种激酶抑制剂;抑制 RETKDREGFRIC50 值分别为5 nM,66 nM 和4 μM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.